Healthcare: MannKind's Back from the Brink
Industry Focus - Podcast tekijän mukaan The Motley Fool
Kategoriat:
A new cash lifeline from United Therapeutics buys the diabetes drugmaker more time to increase sales of its inhaled insulin. Also, make-or-break news is fast approaching for cardiovascular drugmaker, Amarin. MNKD, UTHR, AMRN
